Antimalarial hexahydropyrimidine analogues
US-2025134890-A1 · May 1, 2025 · US
This page is not indexed by search engines while we improve data quality.
Lowe Martin Alexander patents
Lowe Martin Alexander is listed as an inventor on 24 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Lowe Martin Alexander |
| Total patents | 24 |
| First publication | Jun 4, 2015 |
| Latest publication | May 1, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Antimalarial hexahydropyrimidine derivatives
US-2025034118-A1 · Jan 30, 2025 · US
Antimalarial hexahydropyrimidine analogues
US-11479546-B2 · Oct 25, 2022 · US
Antimalarial hexahydropyrimidine analogues
US-2022289685-A1 · Sep 15, 2022 · US
Iminotetrahydropyrimidinone derivatives as plasmepsin V inhibitors
US-11136310-B2 · Oct 5, 2021 · US
Antimalarial Hexahydropyrimidine Analogues
US-2021094941-A1 · Apr 1, 2021 · US
Pharmaceutical 6,5 Heterobicyclic Ring Derivatives
US-2020399268-A1 · Dec 24, 2020 · US
Iminotetrahydropyrimidinone derivatives as plasmepsin v inhibitors
US-2020283416-A1 · Sep 10, 2020 · US
Fused pentacyclic imidazole derivatives as modulators of TNF activity
US-10654861-B2 · May 19, 2020 · US
Iminothiadiazinane dioxide derivatives as plasmepsin V inhibitors
US-10464932-B2 · Nov 5, 2019 · US
Recent patents
Latest publications not already listed above.
Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity
US-10287299-B2 · May 14, 2019 · US
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
US-2019100525-A1 · Apr 4, 2019 · US
Iminothiadiazinane Dioxide Derivatives as Plasmepsin V Inhibitors
US-2019040053-A1 · Feb 7, 2019 · US
Purine derivatives as modulators of TNF activity
US-9988383-B2 · Jun 5, 2018 · US
Benzoxazinone Derivatives and Analogues Thereof as Modulators of TNF Activity
US-2018134728-A1 · May 17, 2018 · US
Tetrahydroimidazopyridine derivatives as modulators of TNF activity
US-9932334-B2 · Apr 3, 2018 · US
Tetrahydroimidazopyridine derivatives as modulators of TNF activity
US-9834553-B2 · Dec 5, 2017 · US
Tetrahydroimidazopyridine Derivatives as Modulators of TNF Activity
US-2017129883-A1 · May 11, 2017 · US
TNF -α modulating benzimidazoles
US-9550737-B2 · Jan 24, 2017 · US
Tetrahydroimidazopyridine Derivatives As Modulators of TNF Activity
US-2016304514-A1 · Oct 20, 2016 · US
Purine Derivatives As Modulators of TNF Activity
US-2016297818-A1 · Oct 13, 2016 · US
Imidazopyridine derivatives as modulators of TNF activity
US-9309243-B2 · Apr 12, 2016 · US
Imidazopyridine Derivatives as Modulators of TNF Activity
US-2015203486-A1 · Jul 23, 2015 · US
TNF -Alpha Modulating Benzimidazoles
US-2015152065-A1 · Jun 4, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ucb Biopharma Sprl | 17 |
| UCB Biopharma SRL | 8 |
| Sanofi Sa | 2 |
| Ucb Biopharma Sprl A Corp | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P29/00 | 15 |
| C07D471/04 | 15 |
| A61P9/00 | 14 |
| A61P35/00 | 14 |
| A61P3/00 | 14 |